Background Live vaccines are generally contraindicated on immunosuppressive therapy
due to safety concerns. However, data are limited to corroborate this practice. Objectives To …

Background Infectious diseases after solid organ transplantation (SOT) are one of the major
complications in transplantation medicine. Vaccination-based prevention is desirable, but …

These updated guidelines from the American Society of Transplantation Infectious Diseases
Community of Practice review the diagnosis, prevention, and management of varicella …

Growing evidence suggests receipt of live‐attenuated viral vaccines after solid organ
transplant (SOT) has occurred and is safe and needed due to lapses in herd immunity. A 2 …

Background. Immunization of varicella-zoster virus (VZV)-seronegative solid organ
transplant (SOT) patients using the live-attenuated varicella vaccine is generally …

Viral infection is a recognized and potentially serious complication in children following solid
organ transplantation. The risks of viral infection are particularly important for infants who …

Live-attenuated vaccines are currently contraindicated in solid-organ transplant recipients.
However, the risk of vaccine-preventable infections is lifelong, and can be particularly …

Varicella zoster virus (VZV) is an exclusively human virus that exposure either through direct
contact with a skin lesion or through airborne spread from respiratory droplets leads to acute …

Vaccine-preventable infections represent a significant burden of disease in solid-organ
transplant (SOT) recipients. Respiratory infections caused by Streptococcus pneumoniae …

The use of live attenuated vaccines in patients with immunosuppressive agents is
contraindicated in package inserts and guidelines in Japan and other countries. However …